---
figid: PMC9310845__BIT-119-1343-g004
pmcid: PMC9310845
image_filename: BIT-119-1343-g004.jpg
figure_link: /pmc/articles/PMC9310845/figure/bit28066-fig-0005/
number: Figure 5
figure_title: ''
caption: Monoclonal antibody (mAb) glycosylation pathway of Chinese hamster ovary
  (CHO) cells when diverted towards N‐acetylglucosamine (GlcNAc) bisection. The overexpression
  of β1,4‐N‐acetylglucosaminyltransferase III (GnTIII) generates bisected glycans,
  which cannot be fucosylated due to the steric hindrance created by the GlcNAc residue
  for c1,6‐FucT. Created with BioRender.com
article_title: 'Strategies to control therapeutic antibody glycosylation during bioprocessing:
  Synthesis and separation.'
citation: Elizabeth Edwards, et al. Biotechnol Bioeng. 2022 Jun;119(6):1343-1358.
year: '2022'

doi: 10.1002/bit.28066
journal_title: Biotechnology and Bioengineering
journal_nlm_ta: Biotechnol Bioeng
publisher_name: John Wiley and Sons Inc.

keywords:
- antibodies
- biosimilars
- CQAs
- downstream glycosylation bioprocessing
- mAbs
- N‐glycosylation

---
